- Home
- ARCT
as 10-17-2024 4:00pm EST
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in the research and development segment of medical applications for nucleic acid-focused technology. The company's product pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU and LUNAR-COV19.
| Founded: | 2013 | Country: | United States |
| Employees: | N/A | City: | SAN DIEGO |
| Market Cap: | 602.7M | IPO Year: | N/A |
| Target Price: | $65.00 | AVG Volume (30 days): | 338.5K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 7 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -2.69 | EPS Growth: | N/A |
| 52 Week Low/High: | $17.52 - $45.00 | Next Earning Date: | 11-12-2024 |
| Revenue: | $163,866,000 | Revenue Growth: | -38.04% |
| Revenue Growth (this year): | 13.46% | Revenue Growth (next year): | 5.17% |
Latest Arcturus Therapeutics Holdings Inc. News
ARCT Breaking Stock News: Dive into ARCT Ticker-Specific Updates for Smart Investing
Zacks
16 days ago
ARCT Stock Up as Updated COVID-19 Jab Betters PFE & BNTX's Comirnaty
Benzinga
17 days ago
Arcturus Therapeutics/CSL Partnered COVID-19 Vaccine Surpasses Pfizer's Comirnaty Shot, Even At Lower Doses
Business Wire
18 days ago
Self-Amplifying mRNA COVID-19 Vaccine Demonstrates Superior Immune Response Compared with mRNA Vaccine at 12 Months Post-Vaccination
Zacks
a month ago
Here's Why Investors Should Invest in Arcturus Stock Now
MT Newswires
a month ago
Arcturus Therapeutics, CSL's Updated Covid-19 Vaccine Approved in Japan
PR Newswire
a month ago
Japan's Ministry of Health, Labor and Welfare Approves CSL and Arcturus Therapeutics' Updated Self-amplifying mRNA COVID-19 Vaccine for Protection against JN.1 Strain, to be Distributed in Japan by Meiji Seika Pharma
Zacks
a month ago
New Strong Buy Stocks for September 13th
Simply Wall St.
a month ago
Top High Growth Tech Stocks to Watch in September 2024
Compare ARCT vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ARCT Arcturus Therapeutics Holdings Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.